This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beyer, W. R.
Right arrow Articles by von Laer, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beyer, W. R.
Right arrow Articles by von Laer, D.

 Previous Article  |  Next Article 

Journal of Virology, January 2001, p. 1061-1064, Vol. 75, No. 2
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.2.1061-1064.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Recombinant Expression of Lymphocytic Choriomeningitis Virus Strain WE Glycoproteins: a Single Amino Acid Makes the Difference

Winfried R. Beyer, Hrvoje Miletic, Wolfram Ostertag, and Dorothee von Laer*

Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg, D-20251 Hamburg, Germany

Received 8 August 2000/Accepted 25 October 2000

Cytoplasmic vector systems are generally used for expression of lymphocytic choriomeningitis virus (LCMV) proteins. However, we achieved high levels of cell surface glycoproteins using a standard nuclear expression plasmid. Expression was independent of other LCMV proteins but was blocked by a missense mutation within the original LCMV(WE) glycoprotein cDNA.


* Corresponding author. Present address: Georg-Speyer-Haus, Paul-Ehrlich-Strasse 42-44, D-60596 Frankfurt, Germany. Phone: 49-69-63395232. Fax: 49-69-63395297. E-mail: laer{at}em.uni-frankfurt.de.


Journal of Virology, January 2001, p. 1061-1064, Vol. 75, No. 2
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.2.1061-1064.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Cosset, F.-L., Marianneau, P., Verney, G., Gallais, F., Tordo, N., Pecheur, E.-I., ter Meulen, J., Deubel, V., Bartosch, B. (2009). Characterization of Lassa Virus Cell Entry and Neutralization with Lassa Virus Pseudoparticles. J. Virol. 83: 3228-3237 [Abstract] [Full Text]  
  • Schildknecht, A., Welti, S., Geuking, M. B., Hangartner, L., van den Broek, M. (2008). Absence of CTL Responses to Early Viral Antigens Facilitates Viral Persistence. J. Immunol. 180: 3113-3121 [Abstract] [Full Text]  
  • Schrempf, S., Froeschke, M., Giroglou, T., von Laer, D., Dobberstein, B. (2007). Signal Peptide Requirements for Lymphocytic Choriomeningitis Virus Glycoprotein C Maturation and Virus Infectivity. J. Virol. 81: 12515-12524 [Abstract] [Full Text]  
  • Miletic, H., Fischer, Y. H., Giroglou, T., Rueger, M. A., Winkeler, A., Li, H., Himmelreich, U., Stenzel, W., Jacobs, A. H., von Laer, D. (2007). Normal Brain Cells Contribute to the Bystander Effect in Suicide Gene Therapy of Malignant Glioma. Clin. Cancer Res. 13: 6761-6768 [Abstract] [Full Text]  
  • Eschli, B., Zellweger, R. M., Wepf, A., Lang, K. S., Quirin, K., Weber, J., Zinkernagel, R. M., Hengartner, H. (2007). Early Antibodies Specific for the Neutralizing Epitope on the Receptor Binding Subunit of the Lymphocytic Choriomeningitis Virus Glycoprotein Fail To Neutralize the Virus. J. Virol. 81: 11650-11657 [Abstract] [Full Text]  
  • Freigang, S., Eschli, B., Harris, N., Geuking, M., Quirin, K., Schrempf, S., Zellweger, R., Weber, J., Hengartner, H., Zinkernagel, R. M. (2007). A lymphocytic choriomeningitis virus glycoprotein variant that is retained in the endoplasmic reticulum efficiently cross-primes CD8+ T cell responses. Proc. Natl. Acad. Sci. USA 104: 13426-13431 [Abstract] [Full Text]  
  • Matter, M., Pavelic, V., Pinschewer, D. D., Mumprecht, S., Eschli, B., Giroglou, T., von Laer, D., Ochsenbein, A. F. (2007). Decreased Tumor Surveillance after Adoptive T-Cell Therapy. Cancer Res. 67: 7467-7476 [Abstract] [Full Text]  
  • Bergthaler, A., Merkler, D., Horvath, E., Bestmann, L., Pinschewer, D. D. (2007). Contributions of the lymphocytic choriomeningitis virus glycoprotein and polymerase to strain-specific differences in murine liver pathogenicity. J. Gen. Virol. 88: 592-603 [Abstract] [Full Text]  
  • Zahn, R. C., Schelp, I., Utermohlen, O., von Laer, D. (2007). A-to-G Hypermutation in the Genome of Lymphocytic Choriomeningitis Virus. J. Virol. 81: 457-464 [Abstract] [Full Text]  
  • Eschli, B., Quirin, K., Wepf, A., Weber, J., Zinkernagel, R., Hengartner, H. (2006). Identification of an N-Terminal Trimeric Coiled-Coil Core within Arenavirus Glycoprotein 2 Permits Assignment to Class I Viral Fusion Proteins. J. Virol. 80: 5897-5907 [Abstract] [Full Text]  
  • Froeschke, M., Basler, M., Groettrup, M., Dobberstein, B. (2003). Long-lived Signal Peptide of Lymphocytic Choriomeningitis Virus Glycoprotein pGP-C. J. Biol. Chem. 278: 41914-41920 [Abstract] [Full Text]  
  • Beyer, W. R., Popplau, D., Garten, W., von Laer, D., Lenz, O. (2003). Endoproteolytic Processing of the Lymphocytic Choriomeningitis Virus Glycoprotein by the Subtilase SKI-1/S1P. J. Virol. 77: 2866-2872 [Abstract] [Full Text]  
  • Lee, K. J., Perez, M., Pinschewer, D. D., de la Torre, J. C. (2002). Identification of the Lymphocytic Choriomeningitis Virus (LCMV) Proteins Required To Rescue LCMV RNA Analogs into LCMV-Like Particles. J. Virol. 76: 6393-6397 [Abstract] [Full Text]  
  • Beyer, W. R., Westphal, M., Ostertag, W., von Laer, D. (2002). Oncoretrovirus and Lentivirus Vectors Pseudotyped with Lymphocytic Choriomeningitis Virus Glycoprotein: Generation, Concentration, and Broad Host Range. J. Virol. 76: 1488-1495 [Abstract] [Full Text]